Company news
Vivos Therapeutics, Inc. news in 2022
Vivos Therapeutics, Inc.'s news releases, calls and decks from 2022, newest first.
Vivos Therapeutics Reports Second and Third Quarter 2022 Financial Results and Provides Operational Update
December 19, 2022
Vivos Therapeutics Schedules Release of Second and Third Quarter 2022 Financial Results and Conference Call
December 15, 2022
Vivos Therapeutics Announces New Revenue Stream Through Strategic Medical Billing Relationship with Nexus Dental Systems
December 14, 2022
Vivos Therapeutics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Third Quarter 2022 Quarterly Report on Form 10-Q
November 27, 2022
Vivos Therapeutics Provides Update on Revenue Recognition Review
November 21, 2022
Vivos Therapeutics Announces Receipt of Notice from Nasdaq Regarding Late Filing of Quarterly Report on Form 10-Q
August 25, 2022
Vivos Therapeutics Provides Update on Second Quarter Earnings Delay
August 21, 2022
Vivos Therapeutics to Reschedule Second Quarter 2022 Financial Results Conference Call
August 14, 2022
Vivos Therapeutics Schedules Second Quarter 2022 Financial Results Conference Call
August 8, 2022
Vivos Therapeutics Announces Multiple Regulatory Clearances in Australia for Its Entire Line of Oral Appliances
July 13, 2022
Vivos Therapeutics Announces Exclusive Distribution Agreement with GM Instruments, Ltd. for the U.S. and Canada
June 28, 2022
Vivos Therapeutics’ SLEEP 2022 Annual Meeting Presentation Highlights Retrospective Study Demonstrating Significant Improvement in Sleep Apnea
June 13, 2022
Vivos Therapeutics to Present at Upcoming SLEEP 2022 Annual Meeting
May 25, 2022
Vivos Therapeutics Reports First Quarter 2022 Financial Results and Operational Update
May 15, 2022
Vivos Therapeutics Schedules First Quarter 2022 Financial Results Conference Call
April 27, 2022
Vivos Therapeutics Opens Third U.S. Multidisciplinary Center to Treat Patients Suffering from Sleep Apnea with The Vivos Method
April 25, 2022
Vivos Therapeutics Schedules Fourth Quarter and Full Year 2021 Financial Results Conference Call
March 30, 2022
Vivos Therapeutics Reports Fourth Quarter and Full Year 2021 Financial Results and Operational Update
March 30, 2022
Vivos Therapeutics Rebrands Proprietary Clinical Protocol for Treating Patients with Breathing and Sleep Disorders
March 2, 2022
Vivos Therapeutics to Present at March 2022 World Sleep Congress in Rome
February 23, 2022
Vivos Therapeutics Files for US Patent on Proprietary New Clinical Protocols After Seeing Further Significant Improvement in Reduction of Key Sleep Apnea Metric
January 26, 2022
Vivos Therapeutics Announces 18X Increase in Sleep Apnea Diagnostic Testing By Vivos Dentists Using SleepImage Technology
January 18, 2022